Huatai Zijin Investment

Huatai Zijin Investment is a venture capital and funds of funds firm established in 2008 and based in Nanjing, China. The firm specializes in investing in life science and medical technology sectors, aiming to support innovative companies within these industries. Huatai Zijin Investment is managed by an executive team that oversees its investment strategies and operations.

Chen Miao

Partner

Wang Qi

Investment Director

44 past transactions

Hengyu Medical

Venture Round in 2025
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Qina New Materials

Venture Round in 2025
Qina New Materials is centered on the manufacturing, exploration, and development of premium special metal materials including wire materials, catalysts, high-temperature alloy master alloys, and electrode meshes for hydrogen production.

XuanBian Technology

Series A in 2024
XuanBian Technology provides intelligent and automated products and solutions for life science smart laboratories. Their products are a cell line screening system, a fully automatic chemical synthesis system, a high throughput drug screening system, a high throughput ELISA workstation, and a microbiology workstation.

Xiushi Biotechnology

Seed Round in 2024
Xiushi Biotechnology Focus on the R&D, production, sales, and technology development services of peptide products.

Falcon Technology

Venture Round in 2024
Falcon Technology builds consumer-grade AR ecosystem and provides users with high-quality AR products and services.

ZhiRen JingXing

Series A in 2024
ZhiRen JingXing is a research and development platform dedicated to the study and manufacture of advanced alloy materials. The company specializes in high-end energetic materials, light alloy composite materials, and soft magnetic metal materials. Additionally, it focuses on additive manufacturing technology and equipment. By concentrating on these areas, ZhiRen JingXing aims to provide innovative material solutions tailored for industrial users, enhancing the capabilities and efficiency of various production processes.

Zinsight

Series B in 2023
Zinsight is a Shanghai-based company focused on designing, developing, and manufacturing electrical machine drives and systems utilizing silicon carbide (SiC) technology. Established in 2019, Zinsight specializes in creating advanced electric drive systems and high-performance power modules that serve various applications, including fuel-cell air compressors, micro turbine generators, and electrical propulsion systems for aircraft and specialized vehicles. The company leverages over a decade of research and development experience in SiC power semiconductors to deliver innovative solutions for high-speed turbine equipment and electrified transportation. Its products play a crucial role in enhancing the efficiency and performance of energy equipment across multiple sectors.

A new energy

Venture Round in 2023
A new energy provides photovoltaic new energy system application solutions is committed to manufacturing and selling N-type high-efficiency photovoltaic cells, components, and system applications, as well as investing in and integrating power station construction and operation. They offer ecological photovoltaic, urban photovoltaic, and offshore PV solutions.

Zigge Technology

Series B in 2023
Zhige Technology develops, manufactures, researches, and sells AR optical display modules, and diffraction grating products.

Hengyu Medical

Series C in 2023
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Eaglenos

Series A in 2023
Eaglenos is an IVD company that specialises in medical POCT, home health care devices, and health management systems. It focuses on chemistry, materials, electronics, software, machinery, and biomedical engineering. It helps in the advancement of electrochemistry, microfluidics, signal acquisition, and automation technologies.

Bestzyme

Venture Round in 2023
Bestzyme is a biotechnology company that specializes in the research, development, and manufacture of enzyme products primarily for the animal feed industry. The company produces a variety of feed enzymes that enhance the quality of livestock feed. In addition to animal nutrition, Bestzyme develops enzymes for industrial applications, including those used in starch processing, baking, winemaking, and textiles. By providing these specialized enzyme solutions, Bestzyme supports clients across multiple sectors, improving efficiency and quality in their respective processes.

New Vision Electronics

Series D in 2023
New Vision Electronics is a national high-tech enterprise focused on the research, development, and manufacturing of advanced automotive visual solutions. The company specializes in products such as windshield head-up displays, augmented reality head-up displays, cabin monitoring systems, transparent A-pillars, and transparent window displays. By leveraging innovative technology, New Vision Electronics aims to enhance the digital experience in smart vehicles. It has established itself as a leading supplier of in-vehicle visual solutions in China, serving notable clients such as NIO, Geely, BAIC, and Chery. Through its commitment to quality and innovation, New Vision Electronics is shaping the future of automotive technology.

Primont

Series B in 2023
Primont is a researcher and producer of surgical instruments and equipment. They offer medically absorbable synthetic sutures, absorbable knot free sutures, non-absorbable surgical sutures, and non absorbable self sealing surgical sutures.

Tingsheng Technology

Series B in 2023
TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digital heart model.

ProBio

Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

InnerMedical

Series D in 2022
InnerMedical focuses on developing advanced diagnostic and treatment solutions for major diseases, particularly in the areas of cancer, cardiovascular, and cerebrovascular conditions. The company specializes in creating minimally invasive medical imaging devices, including intravascular imaging monitors and high-frequency endoscopic machines. InnerMedical has successfully launched the first domestic endoscopic ultrasonic diagnostic equipment, electronic endoscopes, and a medical image processing software platform. Through its innovative technologies, the company aims to enhance diagnostic accuracy and treatment effectiveness in the clinic, particularly for tumors affecting the digestive and respiratory tracts.

Jiemeng Intelligence

Seed Round in 2022
Jiemeng Intelligence specializes in the development, design, and manufacturing of lithium-ion battery coating equipment. The company is dedicated to creating front-end equipment and machinery specifically for the lithium-ion battery industry. By focusing on innovative solutions, Jiemeng Intelligence aims to provide clients with safe, efficient, and intelligent new energy equipment that meets the growing demands of the market.

Proton Bio

Series B in 2022
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To address clients' therapeutic product demands at the pre-clinical, clinical, and commercial stages, the firm offers end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Sanyou Bio

Series B in 2022
Sanyou Biopharmaceuticals Co., Ltd. is a contract research organization based in Shanghai, China, specializing in the research and development of innovative antibody drugs. Founded in 2015, the company offers a comprehensive range of services that includes raw material preparation, lead antibody production, optimization of antibody candidates, therapeutic antibody screening, and the establishment of animal models and cell lines. Sanyou has developed over 20 core technological platforms in recent years, focusing on areas such as antibody drug discovery, engineering, and drug efficacy evaluation. With a state-of-the-art R&D laboratory located in Caohejing Hi-Tech Park, Sanyou aims to provide biopharmaceutical companies with effective solutions to enhance patient treatment outcomes.

Puguang Bio

Seed Round in 2022
Puguang Bio is a developer of in vitro medical diagnostic systems. They create new biochemical sensors by focusing on the gold standard of modern testing technology and satisfying the needs of diverse markets based on customer requirements. It offers technical services to the public and has an all-around arrangement for the four sectors of drug testing, food testing, animal husbandry monitoring, and environmental monitoring.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

TopXGun Robotics

Series B in 2022
TopXgun Robotics, established in 2009 and formally registered in 2015, specializes in developing flying control systems and unmanned aerial vehicles (UAVs). The company focuses on creating high-precision UAVs equipped with advanced object detection sensing technology, ensuring they meet rigorous performance standards. TopXgun's products cater to a variety of industries, including agriculture, forestry plant protection, and law enforcement, providing practical and reliable aerial solutions for diverse applications.

Bostal Drugs

Series B in 2022
Bostal Drugs, founded in 2013 and headquartered in Guangzhou, Guangdong, specializes in the development and manufacture of drug preparation products tailored for new drug delivery systems. The company focuses on pharmaceutical preparation technology platforms that aim to innovate and enhance both new and high-end generic drugs. In addition to its product offerings, Bostal Drugs provides technical development services for pharmaceutical companies, assisting them in the preparation and improvement of their drug formulations. Through its expertise, Bostal Drugs contributes to advancements in the pharmaceutical industry.

Yeelight

Series E in 2021
Yeelight is a developer, manufacturer, and seller of smart lighting products, specializing in a range of smart and wireless LED lighting solutions. The company designs and produces LED lights that can be controlled via mobile phones and wearable devices, allowing users to conveniently adjust their lighting settings from anywhere at any time. Yeelight's focus on innovation and user-friendly technology positions it as a key player in the smart lighting industry.

Xinjunte

Series B in 2021
Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices.

Matridx

Funding Round in 2021
Matridx is a company based in Hangzhou, China, specializing in the development, production, and sales of molecular diagnostic products aimed at infectious diseases. The company offers PDC-Seq, a technology that enables high-throughput sequencing of nucleic acids from samples collected from infected patients. Matridx utilizes advanced molecular technologies, including gene editing techniques and high-throughput sequencing, to create reliable genetic testing solutions. The company's focus is on simplifying, accelerating, and enhancing the diagnostic process for infectious pathogens, ultimately supporting major medical companies in their diagnostic efforts.

HLK Pharmacin

Series B in 2021
HLK Pharmacin is a biotech business that is dedicated to solutions to solve therapies to improve patient outcomes. They use technology from concept to commercialization so that value-added medications can be developed more quickly and affordably. They create reformulated drug solutions using proprietary formulation technology that could enhance the bioavailability and safety of commercially available medication products as well as enhance patient compliance.

B-One

Series B in 2021
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.

Raynovent

Series B in 2020
Raynovent is an innovative biotech company focused on researching and developing new drugs for liver and respiratory diseases. The company aims to create effective treatment therapies for patients suffering from viral and infectious illnesses in these areas. Through its expertise in pharmaceutical biotechnology consulting and technology transfer, Raynovent supports healthcare professionals in diagnosing and treating infectious diseases more effectively.

Abiochem Biotechnology

Series A in 2020
Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on researching and developing biocatalytic and synthetic biology methods, which are applied to large-scale production across various sectors. Its innovations are utilized in pharmaceuticals, health care products, and pesticides, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a provider of bio-intelligent manufacturing solutions for chemical and biological products.

MGI Tech

Series B in 2020
MGI Tech is a company focused on providing effective and affordable healthcare solutions through the development of advanced life science tools. The company produces clinical high-throughput gene sequencers, along with essential equipment, consumables, and reagents that support life science research and healthcare. MGI Tech's multi-omics platforms encompass genetic sequencing, mass spectrometry, medical imaging, and laboratory automation. By offering real-time, comprehensive systems designed for precision medicine and healthcare, MGI Tech aims to enhance healthcare delivery and drive innovation in digital health.

Dima Biotech

Angel Round in 2019
Dima Biotech is a tumor immunotherapy and monoclonal antibody developer, specializing in the development of recombinant monoclonal antibodies for tumor immune products and services. It has the unique RECmAb digital monoclonal antibody technology, which can be used to obtain a variety of genus and high quality. Monoclonal antibodies.

magAssist

Series A in 2019
Suzhou Xinqing Medical Technology Co., Ltd., founded in 2017 by Dr. Xu Bozhen, focuses on the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular illnesses. The company specializes in creating short-term to medium-term ventricular assist devices that leverage advanced fluid mechanics and magnetic suspension technology. These innovations allow the devices to be compatible with various blood types, thereby reducing the risk of incompatibility for patients. With a team of leading experts in artificial heart engineering, the company has successfully developed an artificial heart that holds independent intellectual property rights, positioning itself as a key player in the medical technology sector.

Abiochem Biotechnology

Series A in 2019
Abiochem Biotechnology is a high-tech enterprise specializing in enzyme engineering and genetic engineering technologies. The company focuses on researching and developing biocatalytic and synthetic biology methods, which are applied to large-scale production across various sectors. Its innovations are utilized in pharmaceuticals, health care products, and pesticides, contributing to advancements in green chemistry. Abiochem Biotechnology offers customized genetic and enzyme engineering services, positioning itself as a provider of bio-intelligent manufacturing solutions for chemical and biological products.

TETRA Electronic

Series A in 2017
TETRA ELC is an integrated design, development, manufacturing, and product sales company for inspection robots and photovoltaic cleaning robots. Their products include hanging rail inspection robots, pipe gallery inspection robots, indoor wheeled inspection robots, outdoor wheeled inspection robots, belt conveyor inspection robots, inventory temperature measurement inspection robots, explosion-proof wheeled inspection robots, and photovoltaic cleaning robots.

One Tree Pharmaceutical

Angel Round in 2017
One Tree Pharmaceutical sells prescription drugs. Since then, the retail sector of pharmacy has set the pace for the pharmaceutical industry. It is dominated by nursing items, promotes health services, and supports trendy consumption styles.

Jiahong DentalLab

Post in 2016
Jiahong DentalLab provides denture services. It is dedicated to giving oral patients all over the world denture restoration products and solutions that are more effective and secure. They offer a cnc-pure titanium bracket, a planting guide, a pure titanium light-cured composite resin bridge, an implant suprabridge, a zirconia all-ceramic bridge on the upper part of the implant, a vitaline stent, an active fix peek, a zirconia all-ceramic bridge, and a zirconia all-ceramic crown and bridge.

Enjoy Dental Clinic

Series A in 2016
Enjoy Dental Clinic is a prominent dental care provider based in Beijing, China, established in 2007. It operates as a large-scale dental chain that integrates medical treatment, scientific research, education, and administrative functions. The clinic adheres to standardized practices in oral health treatment, employing advanced techniques such as 3D printing, digital-guided dental implants, and oral digital CT scanning. Additionally, Enjoy Dental Clinic prioritizes aseptic procedures and individualized care, utilizing a "one person, one machine" approach to ensure safety and hygiene. The clinic also offers franchising services, facilitating dental training and clinic development for aspiring dentists, thereby contributing to the growth of dental care expertise in the region.

EVERCARE

Funding Round in 2015
EVERCARE is a plastic surgery and beauty chain group engaged in professional medical cosmetology and integrating clinical practice, scientific research, and teaching. Their services cover plastic surgery, body sculpture, injection plastic surgery, laser cosmetology, traditional medicine cosmetology, oral management, and other medical aesthetic fields. As the center, EVERCARE adheres to the philosophy of medical professional technology and customer satisfaction evaluation.

Jiahong DentalLab

Series A in 2015
Jiahong DentalLab provides denture services. It is dedicated to giving oral patients all over the world denture restoration products and solutions that are more effective and secure. They offer a cnc-pure titanium bracket, a planting guide, a pure titanium light-cured composite resin bridge, an implant suprabridge, a zirconia all-ceramic bridge on the upper part of the implant, a vitaline stent, an active fix peek, a zirconia all-ceramic bridge, and a zirconia all-ceramic crown and bridge.

Xiaoi Robot

Series D in 2014
Xiaoi Robot is an intelligent robot technology provider and platform operator that is specialized in the long-term technology research and development of smart robots. The company covers businesses in telecommunication, finance, government, e-commerce, smart household appliances, automobiles, and other industries. After the constant verification and optimization of actual programs over the past decades, Xiaoi Robot now has the largest industrial knowledge base and encyclopedia base in multiple industries and sectors in the world. It also possesses an advanced intelligent human-machine dialogue engine, which ensures that its robot system process. Established in 2001, Xiaoi Robot has been awarded with many national innovation patents in natural language processing and human-machine interaction. With more than 1 billion users and over 100 billion interactions, it covers more than a hundred countries and establishes the largest intelligent robot cloud service platform in the world.

Times Bright CreSuccess

Angel Round in 2013
Times Bright CreSuccess provides digital learning solutions and response services for enterprises, governments and organizations. They use artificial intelligence and big data technology.

Mandala

Series C in 2011
Mandala is a healthcare IT company that specialises in medical software and information technology services, focusing on electronic medical records and regional medical and public health collaboration. The company provides health and medical big data solutions, serving dozens of provincial and municipal health commissions and nearly a thousand medical institutions nationwide. Their solutions enhance healthcare delivery and streamline medical data management, contributing to improved public health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.